Hampton Sessions

Title: Hampton Sessions: Innovator in Medical Research

Introduction

Hampton Sessions is a notable inventor based in Orlando, FL (US). He has made significant contributions to the field of medical research, particularly in the areas of lipid accumulation and insulin resistance. With a total of 6 patents to his name, Sessions continues to push the boundaries of innovation in healthcare.

Latest Patents

One of his latest patents focuses on modulators of myocyte lipid accumulation and insulin resistance. This patent outlines formulations and methods for reducing blood glucose and increasing insulin signaling in subjects. The formulations include SBI-477 and its analogs, which are designed to inhibit intracellular lipid accumulation and enhance cellular glucose uptake. Additionally, the patent describes methods for treating various Myc-driven cancers, including neuroblastoma and lung adenocarcinoma, among others. Another significant patent involves theranostic nanoparticles for drug delivery, which utilize hyperbranched polyester nanoparticles with specific ligands and detectable isotopes.

Career Highlights

Hampton Sessions has worked with esteemed organizations such as the Sanford Burnham Prebys Medical Discovery Institute and the University of Central Florida Research Foundation, Inc. His work in these institutions has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Throughout his career, Sessions has collaborated with notable colleagues, including Stephen Gardell and Anthony B. Pinkerton. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Hampton Sessions is a distinguished inventor whose work in medical research has led to significant advancements in the treatment of metabolic disorders and cancers. His innovative patents and collaborations highlight his commitment to improving healthcare outcomes.